Researchers reviewed 89 articles to study how certain microRNAs affect neuroblastoma, a type of cancer that primarily affects children. The study looked at how these molecules influence the way cancer cells grow and differentiate. The findings suggest that miR-124, miR-34, and miR-506-3p help these cells mature, while the miR-17-92 cluster prevents them from maturing.
The review also looked at patient data. It found that when miR-124, miR-34, and miR-506-3p are disrupted, patient survival rates tend to decrease. Conversely, the presence of the miR-17-92 cluster was associated with poorer survival outcomes. These findings suggest that these microRNAs play a significant role in the progression of the disease.
It is important to note that this research is currently in the early stages. While these microRNAs show promise as potential new treatments, there are still many hurdles to overcome before they can be used in a clinic. These results are based on laboratory studies and observations, so they do not yet provide a standard for medical treatment.
